Hany Elmariah

2.1k total citations
39 papers, 639 citations indexed

About

Hany Elmariah is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hany Elmariah has authored 39 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 13 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hany Elmariah's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Hany Elmariah is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Hany Elmariah collaborates with scholars based in United States, Australia and Canada. Hany Elmariah's co-authors include Christine H. Chung, Daniel Abate‐Daga, Kedar Kirtane, Kenneth I. Ataga, Melanie E. Garrett, Marilyn J. Telen, Allison E. Ashley‐Koch, Laura M. De Castro, James R. Eckman and Jude Jonassaint and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Hany Elmariah

35 papers receiving 632 citations

Peers

Countries citing papers authored by Hany Elmariah

Since Specialization

Citations

This map shows the geographic impact of Hany Elmariah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hany Elmariah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hany Elmariah more than expected).

Fields of papers citing papers by Hany Elmariah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hany Elmariah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hany Elmariah. The network helps show where Hany Elmariah may publish in the future.

Co-authorship network of co-authors of Hany Elmariah

This figure shows the co-authorship network connecting the top 25 collaborators of Hany Elmariah. A scholar is included among the top collaborators of Hany Elmariah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hany Elmariah. Hany Elmariah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes 2024 ·Transplantation and Cellular Therapy ·Omar Albanyan, Hany Elmariah, (unknown), Jongphil Kim, Rawan Faramand, David A. Sallman, Asmita Mishra, (unknown), Lia Perez, José L. Ochoa-Bayona, Michael L. Nieder, Rami S. Komrokji, (unknown), Hugo F. Fernández, Taiga Nishihori, Joseph A. Pidala, Claudio Anasetti, Nelli Bejanyan	0
2	Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Filip Ionescu, (unknown), (unknown), David A. Sallman, Kendra Sweet, Rami S. Komrokji, Onyee Chan, Andrew Kuykendall, Eric Padron, Rawan Faramand, Nelli Bejanyan, Farhad Khimani, Hany Elmariah, Joseph Pidala, Asmita Mishra, Lia Perez, Taiga Nishihori, Jeffrey E. Lancet	2
3	Measurable Residual Disease Monitoring By Duplex Sequencing for TP53 in the Post Allogeneic Stem Cell Transplantation Study with Eprenetapopt (APR-246) + Azacitidine Strongly Predicts Outcomes 2024 ·Blood ·David A. Sallman, Amy F. McLemore, Rami S. Komrokji, Hany Elmariah, Andrew Kuykendall, Nelli Bejanyan, Onyee Chan, Rawan Faramand, Joseph A. Pidala, Sean Yoder, Lia Perez, Taiga Nishihori, Eric Padron, Hugo F. Fernández, Jeffrey E. Lancet, Asmita Mishra	1
4	JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results 2023 ·Blood ·Joseph Pidala, Shernan G. Holtan, Kelly Walton, Jongphil Kim, Hany Elmariah, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Claudio Anasetti, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller, Veronika Bachanová, (unknown), Brian C. Betts	1
5	Trends and in‐hospital cardiac complications in patients with atrial fibrillation undergoing allogeneic stem cell transplant: A National Inpatient Sample analysis (2002–2019) 2023 ·European Journal Of Haematology ·(unknown), (unknown), Moazzam Shahzad, Salman Zahid, (unknown), Muhammad Osama, Hany Elmariah	1
6	Phase I Trial of Allogeneic Donor Gamma Delta T Cell Infusion Post-Hematopoietic Cell Transplantation, an Interim Safety Report 2023 ·Blood ·Nelli Bejanyan, Hany Elmariah, Kayla Reid, Bin Yu, Jongphil Kim, Cheryl A. Cox, (unknown), Rawan Faramand, Christopher Cubitt, Hien Liu, Justin C. Boucher, José A. Guevara-Patiño, David A. Sallman, Jeffrey E. Lancet, Joseph A. Pidala, (unknown), Frederick L. Locke, Claudio Anasetti, Marco L. Davila	1
7	Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies 2022 ·Blood Advances ·Caner Saygin, Gregory W. Roloff, Christopher N Hahn, Rakchha Chhetri, Saar Gill, Hany Elmariah, Chetasi Talati, (unknown), Guimin Gao, (unknown), Michael R. Bishop, Satyajit Kosuri, Soma Das, Deepak Singhal, Parvathy Venugopal, Claire C. Homan, Anna Brown, Hamish S. Scott, Devendra Hiwase, Lucy A. Godley	23
8	BMT for Myelodysplastic Syndrome: When and Where and How 2022 ·Frontiers in Oncology ·Akriti Jain, Hany Elmariah	10
9	Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies 2022 ·Blood ·Caner Saygin, Gregory W. Roloff, Christopher N Hahn, Rakchha Chhetri, Saar Gill, Hany Elmariah, Chetasi Talati, (unknown), (unknown), (unknown), Michael R. Bishop, Satyajit Kosuri, Soma Das, Deepak Singhal, Parvathy Venugopal, Claire C. Homan, Anna Brown, Hamish S. Scott, Devendra Hiwase, Lucy A. Godley	1
10	Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results 2021 ·Clinical Cancer Research ·Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, Michael L. Nieder, Elizabeth M. Sagatys, Shernan G. Holtan, Nicholas J. Lawrence, Harshani R. Lawrence, Bruce R. Blazar, Claudio Anasetti, Saı̈d M. Sebti, Brian C. Betts	15
11	Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes 2021 ·Blood ·David A. Sallman, Hany Elmariah, Kendra Sweet, Chetasi Talati, Asmita Mishra, Cheryl A. Cox, Roshanak Tolouei Semnani, Rutul R. Shah, Helen Sabzevari, (unknown), (unknown), Amy Lankford, Chen Wang, Eric Padron, Andrew Kuykendall, Rami S. Komrokji, Jeffrey E. Lancet, Marco L. Davila, Nelli Bejanyan	21
12	Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes 2021 ·Transplantation and Cellular Therapy ·Paul V. O’Donnell, Claudio G. Brunstein, Ephraim J. Fuchs, Mei‐Jie Zhang, (unknown), Joseph H. Antin, Eric Leifer, Hany Elmariah, Michael R. Grunwald, Hamza Hashmi, Mary M. Horowitz, John Magenau, Navneet S. Majhail, Filippo Milano, Lawrence E. Morris, Andrew R. Rezvani, Joseph P. McGuirk, Richard J. Jones, Mary Eapen	10
13	Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide 2021 ·Transplantation and Cellular Therapy ·Salman Otoukesh, Hany Elmariah, Dongyun Yang, Mary C. Clark, (unknown), Haris Ali, (unknown), Shukaib Arslan, Taiga Nishihori, Ryotaro Nakamura, Joseph Pidala, Guido Marcucci, Stephen J. Forman, Claudio Anasetti, Monzr M. Al Malki, Nelli Bejanyan	12
14	Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study 2021 ·Leukemia ·Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, (unknown), Anurag K. Singh, Sameem Abedin, Amy E. DeZern, Richard J. Jones, Vikas Gupta, Aaron T. Gerds, Tania Jain	20
15	Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide 2020 ·Biology of Blood and Marrow Transplantation ·Amy E. DeZern, Hany Elmariah, Marianna Zahurak, Gary L. Rosner, Douglas E. Gladstone, Syed Abbas Ali, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina D. Wagner‐Johnston, Richard F. Ambinder, Robert A. Brodsky, Kenneth R. Cooke, Leo Luznik, Ephraim J. Fuchs, Javier Bolaños‐Meade, Richard J. Jones	22
16	Delayed CD4+ T-Cell but Faster B-Cell Immune Reconstitution after Ptcy-Based Compared to Conventional Gvhd Prophylaxis after Allogeneic Transplantation 2020 ·Biology of Blood and Marrow Transplantation ·(unknown), Junmin Zhou, Joseph A. Pidala, Taiga Nishihori, Michael L. Nieder, Hany Elmariah, Rawan Faramand, Aleksandr Lazaryan, Aliyah Baluch, Asmita Mishra, Lia Perez, Leonel Ochoa, Hien Liu, Marco L. Davila, Michael D. Jain, Frederick L. Locke, Melissa Alsina, Jongphil Kim, Nelli Bejanyan, Farhad Khimani	2
17	Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment 2019 ·Current Hematologic Malignancy Reports ·Hany Elmariah, Amy E. DeZern	9
18	Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes 2019 ·Journal of Oncology Practice ·Aanika Balaji, Jiajia Zhang, Beatriz Wills, Kristen A. Marrone, Hany Elmariah, Mark Yarchoan, Jacquelyn W. Zimmerman, (unknown), Deepti Venkatraman, Deborah K. Armstrong, Daniel A. Laheru, Ranee Mehra, Won Jin Ho, Joshua E. Reuss, Joseph Heng, Paz J. Vellanki, Ross C. Donehower, Matthias Holdhoff, Jarushka Naidoo	38
19	Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results 2018 ·Seminars in Hematology ·Hany Elmariah, Ephraim J. Fuchs	6
20	Role of Alternative Donor Allogeneic Transplants in the Therapy of Acute Myeloid Leukemia 2017 ·Journal of the National Comprehensive Cancer Network ·Hany Elmariah, Keith W. Pratz	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact